Good evening :)
Place Order
Add to Watchlist

Anuh Pharma Ltd

ANUHPHR

Anuh Pharma Ltd

ANUHPHR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,111 cr, stock is ranked 1,427
High RiskStock is 3.49x as volatile as Nifty
219.700.98% (+2.14)
219.700.98% (+2.14)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,111 cr, stock is ranked 1,427
High RiskStock is 3.49x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,111 cr, stock is ranked 1,427
High RiskStock is 3.49x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
18.833.821.13%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.726.720.52%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Anuh Pharma Ltd specializes in manufacturing and selling active pharmaceutical ingredients and corticosteroids for various therapeutic applications.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 15.16%, vs industry avg of 9.04%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.15% to 0.17%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 20.79%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue329.74213.73245.47325.36311.17442.50491.85533.60659.10653.45
Raw Materialssubtract251.07148.76184.07249.16243.67327.49382.54388.00501.90569.19
Power & Fuel Costsubtract3.483.074.094.796.318.668.8011.0212.37
Employee Costsubtract6.587.228.9010.1413.3614.2915.1017.1519.39
Selling & Administrative Expensessubtract10.997.458.539.988.9011.1712.0713.2815.50
Operating & Other expensessubtract16.5516.9614.1816.6311.4825.2320.6746.2322.09
Depreciation/Amortizationsubtract2.261.971.831.667.0315.0811.969.708.588.23
Interest & Other Itemssubtract0.860.720.450.601.262.031.580.750.960.54
Taxes & Other Itemssubtract12.137.546.909.044.8510.128.5611.2918.2516.46
EPS5.154.003.304.662.865.676.107.2211.9911.78
DPS1.251.251.381.381.381.501.752.002.502.50
Payout ratio0.240.310.420.290.480.260.290.280.210.21
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF

Investor Presentation

Jun 22PDF
FY 2021

Annual report

PDF

Investor Presentation

May 25PDF
Feb 11PDF
Feb 11PDF
+2 more
FY 2022

Annual report

PDF

Investor Presentation

Nov 12PDF
Nov 12PDF
Aug 9PDF
FY 2023

Annual report

PDF

Investor Presentation

Jun 3PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Anuh Pharma Ltd18.513.821.13%
Sun Pharmaceutical Industries Ltd46.636.650.73%
Cipla Ltd29.524.540.86%
Mankind Pharma Ltd61.9412.37—

Price Comparison

Compare ANUHPHR with any stock or ETF
Compare ANUHPHR with any stock or ETF
ANUHPHR
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding69.92%0.00%0.00%0.02%30.06%

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Shareholding History

SepDec '23MarJunSepDec '240.00%0.00%0.03%0.03%0.02%0.02%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

Increasing Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

ANUHPHR has increased dividends consistently over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 1.13%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹11.27 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateAug 16, 2024

Final
Final | Div/Share: ₹2.50

Dividend/Share

₹2.50

Ex DateEx Date

Aug 16, 2024

Cash Dividend

Ex DateEx DateAug 11, 2023

Final
Final | Div/Share: ₹2.00

Dividend/Share

₹2.00

Ex DateEx Date

Aug 11, 2023

Cash Dividend

Ex DateEx DateAug 3, 2022

Final
Final | Div/Share: ₹1.75

Dividend/Share

₹1.75

Ex DateEx Date

Aug 3, 2022

Cash Dividend

Ex DateEx DateAug 17, 2021

Final
Final | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

Aug 17, 2021

Cash Dividend

Ex DateEx DateMar 5, 2020

Interim
Interim | Div/Share: ₹2.75

Dividend/Share

₹2.75

Ex DateEx Date

Mar 5, 2020

News & Opinions
Earnings
Anuh Pharma standalone net profit rises 8.75% in the September 2024 quarter

Net profit of Anuh Pharma rose 8.75% to Rs 15.04 crore in the quarter ended September 2024 as against Rs 13.83 crore during the previous quarter ended September 2023. Sales rose 10.98% to Rs 165.95 crore in the quarter ended September 2024 as against Rs 149.53 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales165.95149.53 11 OPM %10.1712.01 - PBDT20.1120.02 0 PBT18.1917.87 2 NP15.0413.83 9 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Anuh Pharma to conduct board meeting

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Anuh Pharma to announce Quarterly Result

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Anuh Pharma standalone net profit declines 19.06% in the June 2024 quarter

Net profit of Anuh Pharma declined 19.06% to Rs 9.51 crore in the quarter ended June 2024 as against Rs 11.75 crore during the previous quarter ended June 2023. Sales declined 14.60% to Rs 137.91 crore in the quarter ended June 2024 as against Rs 161.48 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales137.91161.48 -15 OPM %7.668.65 - PBDT14.1517.42 -19 PBT12.2715.41 -20 NP9.5111.75 -19 Powered by Capital Market - Live

4 months agoCapital Market - Live

Anuh Pharma standalone net profit rises 892.22% in the March 2022 quarter

2 years agoBusiness Standard

Anuh Pharma standalone net profit rises 78.23% in the December 2021 quarter

2 years agoBusiness Standard

Anuh Pharma Standalone September 2021 Net Sales At Rs 108.74 Crore, Down 3.11% Y-o-Y

3 years agoMoneycontrol

Anuh Pharma standalone net profit rises 29.52% in the September 2021 quarter

3 years agoBusiness Standard

Anuh Pharma standalone net profit declines 66.57% in the June 2021 quarter

3 years agoBusiness Standard

Anuh Pharma reports standalone net profit of Rs 0.90 crore in the March 2021 quarter

3 years agoBusiness Standard